Chemistry Ventures targets $500M for second fund

Chemistry Ventures, a venture capital firm launched two years ago by alumni of Bessemer, Index Ventures, and Andreessen Horowitz, is seeking to raise $500 million for its second fund, as indicated in a recent SEC filing. The firm was founded by Mark Goldberg, Ethan Kurzweil, and Kristina Shen, and it initially launched with a $350 million fund. Chemistry Ventures focuses on investing in early-stage startups that build developer tools, fintech, and infrastructure.

Some of its notable portfolio companies include Granola, Decagon, Persona, Serval, and Nova Intelligence. The founders of Chemistry Ventures bring a wealth of experience from their previous roles at major venture capital firms. Goldberg previously worked at Index Ventures, Kurzweil was with Bessemer, and Shen worked with Andreessen Horowitz.

The trio established Chemistry Ventures to leverage their collective expertise. According to The Wall Street Journal, Chemistry Ventures' second fund has already surpassed its fundraising target and is expected to close soon. The firm did not immediately respond to a request for comment.

Why this matters: The successful fundraising efforts of Chemistry Ventures signal a strong vote of confidence from investors in the firm's strategy and leadership. This development also highlights the growing demand for venture capital funding in the areas of developer tools, fintech, and infrastructure. As the firm looks to deploy its new fund, businesses and consumers can expect to see continued innovation in these sectors.

For developers and startups, this means access to more capital and resources to build and scale their products. However, it remains to be seen how Chemistry Ventures will differentiate itself from other venture capital firms and navigate the increasingly competitive startup funding environment.